After confirming tumor growth inhibition in the absence of evident toxicity (Fig. 4B, C), spleens were collected from treated and control mice, and splenocytes were re-stimulated ex vivo with CD4 and CD8 epitope peptides derived from universal tumor associated antigens (Telomerase and Survivin). The gene discussed is BIRC5; the disease is neoplasm.